Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.33 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.33 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | RARB | P10826 | 1/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.31 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.31 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24292884 | 0.89 | MEN1 (0.41) | TP53CYP1A2MEN1KMT2AL3MBTL1 | |
| SCHEMBL26006466 | 0.87 | MEN1 (0.46) | TP53CYP1A2MEN1KMT2AL3MBTL1 | |
| SCHEMBL26306829 | 0.87 | CYP3A4 (0.46) | TP53CYP1A2MEN1KMT2A | |
| SCHEMBL23445601 | 0.83 | RARB (0.43) | TP53CYP1A2RARARARBRARG | |
| SCHEMBL31375644 | 0.82 | RARB (0.40) | TP53CYP1A2RARARARBRARG | |
| SCHEMBL25491148 | 0.82 | RARB (0.40) | TP53CYP1A2RARARARBRARG | |
| SCHEMBL23446728 | 0.82 | RARB (0.39) | TP53CYP1A2RARARARBRARG | |
| SCHEMBL27395223 | 0.81 | RARB (0.50) | TP53CYP1A2RARARARBRARG | |
| SCHEMBL27395411 | 0.81 | PDK2 (0.34) | TP53CYP1A2PDK2PDK4 | |
| SCHEMBL27395020 | 0.80 | RARB (0.41) | RARARARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250019340-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2025-01-16 | — | — | US | disclosed |
| WO-2023085670-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-05-19 | — | — | WO | disclosed |
| US-20230061019-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2023-03-02 | — | — | US | disclosed |
| EP-3907228-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2021-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250019340-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | OR10J3, CRY2, CRY1 | TP53 2852/4885CYP1A2 1552/4885PDK1 3144/4885 |
| US-20230061019-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, LEF1 | TP53 2764/4885CYP1A2 47/4885PDK1 4283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.